Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 18.85% | -32.12% | 90.27% | 24.59% | 321.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.85% | -32.12% | 90.27% | 24.59% | 321.24% |
| Cost of Revenue | 5.79% | -53.36% | 73.43% | 60.58% | 340.69% |
| Gross Profit | 25.07% | -10.08% | 98.86% | 13.86% | 313.16% |
| SG&A Expenses | 28.46% | 9.78% | 27.43% | 15.87% | -1.45% |
| Depreciation & Amortization | -17.63% | -21.35% | -13.16% | -1.48% | -2.11% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.47% | -10.80% | 13.12% | 5.64% | 0.01% |
| Operating Income | -26.58% | -19.40% | 24.83% | 6.05% | 33.73% |
| Income Before Tax | -29.66% | -6.95% | 18.02% | 88.39% | 45.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.66% | -6.95% | 18.02% | 88.39% | 45.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.66% | -6.95% | 18.02% | 88.39% | 45.89% |
| EBIT | -26.58% | -19.40% | 24.83% | 6.05% | 33.73% |
| EBITDA | -28.78% | -21.91% | 25.27% | 6.29% | 34.78% |
| EPS Basic | -29.65% | -6.95% | 18.02% | 92.63% | 72.08% |
| Normalized Basic EPS | -27.74% | -21.28% | 19.83% | 61.64% | 71.70% |
| EPS Diluted | -29.65% | -6.95% | 18.02% | 92.63% | 72.08% |
| Normalized Diluted EPS | -27.74% | -21.28% | 19.83% | 61.64% | 71.70% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 57.66% | 93.80% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 57.66% | 93.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |